Katz AI, Emmanouel DS, Lindheimer MD. Thyroid hormone and the kidney. Nephron. 1975;3–5:223–49.
Iglesias P, Diez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009;4:503–15.
Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrol. 2012;1:22–6.
Dousdampanis P, Trigka K, Vagenakis GA, Fourtounas C. The thyroid and the kidney: a complex interplay in health and disease. Int J Artif Organs. 2014;1:1–12.
Braunlich H. Postnatal development of kidney function in rats receiving thyroid hormones. Exp Clin Endocrinol. 1984;3:243–50.
Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012;2:204–13.
Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T. Mechanism of hyperthyroidism-induced renal hypertrophy in rats. J Endocrinol. 1998;1:9–14.
Pracyk JB, Slotkin TA. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney. J Dev Physiol. 1991;4:251–61.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;7:501–9.
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;15:1725–35.
Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, et al. Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother. 2009;10:742–53.
Koch CA, Chrousos GP. Overview of endocrine hypertension. [Updated Oct 2016]. In: Chrousos G, editor. Adrenal disease and function. Endotext [Internet]. Available: http://www.endotext.org/section/adrenal/.
Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;6:513–20.
Kotsis V, Alevizaki M, Stabouli S, Pitiriga V, Rizos Z, Sion M, et al. Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study. J Hypertens. 2007;5:993–9.
Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010;11:1559–65.
Vargas F, Moreno JM, Rodriguez-Gomez I, Wangensteen R, Osuna A, Alvarez-Guerra M, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol. 2006;2:197–212.
Ichihara A, Kobori H, Miyashita Y, Hayashi M, Saruta T. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol. 1998;2(Pt 1):E224–31.
Vargas F, Rodriguez-Gomez I, Vargas-Tendero P, Jimenez E, Montiel M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol. 2012;1:25–36.
van Hoek I, Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen Comp Endocrinol. 2009;3:205–15.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;13:1296–305.
Zimmerman RS, Ryan J, Edwards BS, Klee G, Zimmerman D, Scott N, et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol. 1988;1(Pt 2):R61–6.
Singer MA. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am J Kidney Dis. 2001;1:164–78.
Schmid C, Brandle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem. 2004;1:228–31.
Sato Y, Nakamura R, Satoh M, Fujishita K, Mori S, Ishida S, et al. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res. 2005;6:550–7.
Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;3:1047–52.
Sun MT, Hsiao FC, Su SC, Pei D, Hung YJ. Thyrotropin as an independent factor of renal function and chronic kidney disease in normoglycemic euthyroid adults. Endocr Res. 2012;3:110–6.
Gopinath B, Harris DC, Wall JR, Kifley A, Mitchell P. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas. 2013;2:159–64.
Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996;2:195–8.
den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol. 2005;4:423–7.
Asvold BO, Bjoro T, Vatten LJ. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur J Endocrinol. 2011;1:101–5.
Karanikas G, Schutz M, Szabo M, Becherer A, Wiesner K, Dudczak R, et al. Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol. 2004;1:41–5.
Capasso G, De Tommaso G, Pica A, Anastasio P, Capasso J, Kinne R, et al. Effects of thyroid hormones on heart and kidney functions. Miner Electrolyte Metab. 1999;1–2:56–64.
Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta. 2003;1–2:87–90.
Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;5:1944–7.
Hataya Y, Igarashi S, Yamashita T, Komatsu Y. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clin Exp Nephrol. 2013;4:525–31.
Shin DH, Lee MJ, Kim SJ, Oh HJ, Kim HR, Han JH, et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2012;8:2732–40.
Shin DH, Lee MJ, Lee HS, Oh HJ, Ko KI, Kim CH, et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid. 2013;6:654–61.
Suher M, Koc E, Ata N, Ensari C. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail. 2005;6:739–42.
Barlet C, Doucet A. Lack of stimulation of kidney Na-K-ATPase by thyroid hormones in long-term thyroidectomized rabbits. Pflugers Arch. 1986;4:428–31.
Michael UF, Barenberg RL, Chavez R, Vaamonde CA, Papper S. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest. 1972;6:1405–12.
Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet. 1997;9080:755–6.
Schmitt R, Klussmann E, Kahl T, Ellison DH, Bachmann S. Renal expression of sodium transporters and aquaporin-2 in hypothyroid rats. Am J Physiol Ren Physiol. 2003;5:F1097–104.
Marcos Morales M, Purchio Brucoli HC, Malnic G, Gil LA. Role of thyroid hormones in renal tubule acidification. Mol Cell Biochem. 1996;1:17–21.
Haro JM, Sabio JM, Vargas F. Renal beta-adrenoceptors in thyroxine-treated rats. J Endocrinol Investig. 1992;8:605–8.
Michel B, Grima M, Coquard C, Welsch C, Barthelmebs M, Imbs JL. Effects of triiodothyronine and dexamethasone on plasma and tissue angiotensin converting enzyme in the rat. Fundam Clin Pharmacol. 1994;4:366–72.
Rodriguez-Gomez I, Banegas I, Wangensteen R, Quesada A, Jimenez R, Gomez-Morales M, et al. Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats. J Endocrinol. 2013;1:43–51.
Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;5:704–28.
Fazio S, Palmieri EA, Lombardi G and Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004:31–50.
Woeber KA. Thyrotoxicosis and the heart. N Engl J Med. 1992;2:94–8.
Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8:596–9.
Iglesias P, Acosta M, Sanchez R, Fernandez-Reyes MJ, Mon C, Diez JJ. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol. 2005;1:66–72.
Asmah BJ, Wan Nazaimoon WM, Norazmi K, Tan TT, Khalid BA. Plasma renin and aldosterone in thyroid diseases. Horm Metab Res. 1997;11:580–3.
Syme HM. Cardiovascular and renal manifestations of hyperthyroidism. Vet Clin North Am Small Anim Pract. 2007;4:723–43. vi.
Conger JD, Falk SA, Gillum DM. The protective mechanism of thyroidectomy in a rat model of chronic renal failure. Am J Kidney Dis. 1989;3:217–25.
Graves TK, Olivier NB, Nachreiner RF, Kruger JM, Walshaw R, Stickle RL. Changes in renal function associated with treatment of hyperthyroidism in cats. Am J Vet Res. 1994;12:1745–9.
Kimmel M, Braun N, Alscher MD. Influence of thyroid function on different kidney function tests. Kidney Blood Press Res. 2012;1:9–17.
Wijkhuisen A, Djouadi F, Vilar J, Merlet-Benichou C, Bastin J. Thyroid hormones regulate development of energy metabolism enzymes in rat proximal convoluted tubule. Am J Physiol. 1995;4(Pt 2):F634–42.
Baum M, Dwarakanath V, Alpern RJ, Moe OW. Effects of thyroid hormone on the neonatal renal cortical Na+/H+ antiporter. Kidney Int. 1998;5:1254–8.
Alcalde AI, Sarasa M, Raldua D, Aramayona J, Morales R, Biber J, et al. Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology. 1999;4:1544–51.
Wang W, Li C, Summer SN, Falk S, Schrier RW. Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int. 2007;9:1088–94.
Kumar V, Prasad R. Molecular basis of renal handling of calcium in response to thyroid hormone status of rat. Biochim Biophys Acta. 2002;3:331–43.
Pothiwala P, Levine SN. Analytic review: thyrotoxic periodic paralysis: a review. J Intensive Care Med. 2010;2:71–7.
Brohee D, Delespesse G, Debisschop MJ, Bonnyns M. Circulating immune complexes in various thyroid diseases. Clin Exp Immunol. 1979;3:379–83.
Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;5:607–14.
Becker BA, Fenves AZ, Breslau NA. Membranous glomerulonephritis associated with Graves’ disease. Am J Kidney Dis. 1999;2:369–73.
Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM. Proteinuria in autoimmune thyroid disease. Acta Endocrinol. 1985;3:341–7.
Berthe E, Henry-Amar M, Michels JJ, Rame JP, Berthet P, Babin E, et al. Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2004;5:685–91.
Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;2:504–15.
Prinzi N, Sorrenti S, Baldini E, De Vito C, Tuccilli C, Catania A, et al. Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients. PLoS One. 2015;3, e0122958.
Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, et al. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid. 2001;8:795–804.
Liou MJ, Lin JD, Chung MH, Liau CT, Hsueh C. Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol. 2005;4:438–42.
von Falck C, Beer G, Gratz KF, Galanski M. Renal metastases from follicular thyroid cancer on SPECT/CT. Clin Nucl Med. 2007;9:751–2.
Moudouni S, En-Nia I, Rioux-Leclerc N, Patard JJ, Guille F, Lobel B. Renal metastasis of thyroid carcinoma. Prog Urol. 2001;4:670–2.
Mello AM, Isaacs R, Petersen J, Kronenberger S, McDougall IR. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis. Clin Nucl Med. 1994;9:776–81.
Daumerie C, Vynckier S, Caussin J, Jadoul M, Squifflet JP, de Patoul N, et al. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis. Thyroid. 1996;4:301–4.
Kaptein EM, Levenson H, Siegel ME, Gadallah M, Akmal M. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy. J Clin Endocrinol Metab. 2000;9:3058–64.
Guo QY, Zhu QJ, Liu YF, Zhang HJ, Ding Y, Zhai WS, et al. Steroids combined with levothyroxine to treat children with idiopathic nephrotic syndrome: a retrospective single-center study. Pediatr Nephrol. 2014;6:1033–8.
Kaptein EM, Feinstein EI, Massry SG. Thyroid hormone metabolism in renal diseases. Contrib Nephrol. 1982:122–35.
Liu H, Yan W, Xu G. Thyroid hormone replacement for nephrotic syndrome patients with euthyroid sick syndrome: a meta-analysis. Ren Fail. 2014;9:1360–5.
Kaptein EM, Hoopes MT, Parise M, Massry SG. rT3 metabolism in patients with nephrotic syndrome and normal GFR compared with normal subjects. Am J Physiol. 1991;4(Pt 1):E641–50.
Chadha V, Alon US. Bilateral nephrectomy reverses hypothyroidism in congenital nephrotic syndrome. Pediatr Nephrol. 1999;3:209–11.
Etling N, Lenoir G, Gehin-Fouque F. Thyroid function in a child with nephrotic syndrome evolving to renal failure. Arch Fr Pediatr. 1980;8:545–8.
Vachvanichsanong P, Mitarnun W, Tungsinmunkong K, Dissaneewate P. Congenital and infantile nephrotic syndrome in Thai infants. Clin Pediatr. 2005;2:169–74.
Muranjan MN, Kher AS, Nadkarni UB, Kamat JR. Congenital nephrotic syndrome with clinical hypothyroidism. Indian J Pediatr. 1995;2:233–5.
Mattoo TK. Hypothyroidism in infants with nephrotic syndrome. Pediatr Nephrol. 1994;6:657–9.
Holmberg C, Antikainen M, Ronnholm K, Ala Houhala M, Jalanko H. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 1995;1:87–93.
Gurkan S, Dikman S, Saland MJ. A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr Nephrol. 2009;1:193–7.
Valentin M, Bueno B, Gutierrez E, Martinez A, Gonzalez E, Espejo B. et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. Nefrologia. 2004:43–8.
Grcevska L, Polenakovic M, Petrusevska G. Membranous nephropathy associated with thyroid disorders. Nephron. 2000;4:534–5.
Weetman AP, Pinching AJ, Pussel BA, Evans DJ, Sweny P, Rees AJ. Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol. 1981;1:50–1.
Enriquez R, Sirvent AE, Amoros F, Andrada E, Cabezuelo JB, Reyes A. IgA nephropathy and autoimmune thyroiditis. Clin Nephrol. 2002;5:406–7.
Illies F, Wingen AM, Bald M, Hoyer PF. Autoimmune thyroiditis in association with membranous nephropathy. J Pediatr Endocrinol Metab. 2004;1:99–104.
O’Regan S, Fong JS, Kaplan BS, Chadarevian JP, Lapointe N, Drummond KN. Thyroid antigen-antibody nephritis. Clin Immunol Immunopathol. 1976;3:341–6.
Mizuno M, Hasegawa H, Fujishiro T, Murai S, Yanai T, Kojima K, et al. Chronic thyroiditis complicated by nephrotic syndrome and marked hydroureteronephrosis. Nihon Jinzo Gakkai Shi. 1987;5:561–9.
Akikusa B, Kondo Y, Iemoto Y, Iesato K, Wakashin M. Hashimoto’s thyroiditis and membranous nephropathy developed in progressive systemic sclerosis (PSS). Am J Clin Pathol. 1984;2:260–3.
Iwaoka T, Umeda T, Nakayama M, Shimada T, Fujii Y, Miura F, et al. A case of membranous nephropathy associated with thyroid antigens. Jpn J Med. 1982;1:29–34.
Horvath Jr F, Teague P, Gaffney EF, Mars DR, Fuller TJ. Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med. 1979;5:901–4.
Tanwani LK, Lohano V, Broadstone VL, Mokshagundam SP. Minimal change nephropathy and Graves’ disease: report of a case and review of the literature. Endocr Pract. 2002;1:40–3.
Mahjoub S, Ben Dhia N, Achour A, Zebidi A, Frih A, Elmay M. Primary hypothyroidism and glomerular involvement. Ann Endocrinol. 1991;4:289–92.
Ikeda K, Maruyama Y, Yokoyama M, Kato N, Yamanoto H, Kaguchi Y, et al. Association of Graves’ disease with Evans’ syndrome in a patient with IgA nephropathy. Intern Med. 2001;10:1004–10.
Dizdar O, Kahraman S, Genctoy G, Ertoy D, Arici M, Altun B, et al. Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto’s thyroiditis. Nephrol Dial Transplant. 2004;4:988–9.
Nishimoto A, Tomiyoshi Y, Sakemi T, Kanegae F, Nakamura M, Ikeda Y, et al. Simultaneous occurrence of minimal change glomerular disease, sarcoidosis and Hashimoto’s thyroiditis. Am J Nephrol. 2000;5:425–8.
Kagiyama S, Tsuruta H, Tominaga M, Morishita K, Doi Y, Onoyama K. Minimal-change nephrotic syndrome and acute renal failure in a patient with aged onset insulin-dependent diabetes mellitus and autoimmune thyroiditis. Am J Nephrol. 1999;3:369–72.
Calder EA, Penhale WJ, Barnes EW, Irvine WJ. Evidence for circulating immune complexes in thyroid disease. Br Med J. 1974;5909:30–1.
Ebihara I, Hirayama K, Usui J, Seki M, Higuchi F, Oteki T, et al. Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism. Clin Exp Nephrol. 2006;3:216–21.
Spronk PE, Weening JJ, Schut NH. Eosinophilic tubulo-interstitial nephritis associated with iridocyclitis and thyreoiditis. Neth J Med. 2001;1:35–8.
Hudde T, Heinz C, Neudorf U, Hoeft S, Heiligenhaus A, Steuhl KP. Tubulointerstitial nephritis and uveitis (TINU syndrome)—comorbidity and complications in four patients. Klin Monatsbl Augenheilkd. 2002;7:528–32.
Asproudis I, Zafeiropoulos P, Katsanos A, Skamantzoura E and Sionti I. Tubulointerstitial nephritis and uveitis syndrome with concomitant Hashimoto’s thyroiditis. J Pediatr Ophthalmol Strabismus. 2013:e1-3.
Sasaki H, Joh K, Ohtsuka I, Ohta H, Ohhashi T, Hoashi S, et al. Interstitial nephritis associated with glomerulonephritis in a patient with Hashimoto’s disease and idiopathic portal hypertension. Intern Med. 1992;5:641–8.
Wang F, Pan W, Wang H, Zhou Y, Wang S, Pan S. The impacts of thyroid function on the diagnostic accuracy of cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study. Crit Care. 2014;1:R9.
Iglesias P, Olea T, Vega-Cabrera C, Heras M, Bajo MA, del Peso G, et al. Thyroid function tests in acute kidney injury. J Nephrol. 2013;1:164–72.
Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, et al. The thyroid in end-stage renal disease. Medicine (Baltimore). 1988;3:187–97.
Kaptein EM, Levitan D, Feinstein EI, Nicoloff JT, Massry SG. Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am J Nephrol. 1981;3–4:138–43.
Targher G, Chonchol M, Zoppini G, Salvagno G, Pichiri I, Franchini M, et al. Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis. Clin Chem Lab Med. 2009;11:1367–71.
Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;5:1296–300.
Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes. 2002;8:408–15.
Rhee CM, Kalantar-Zadeh K, Streja E, Carrero JJ, Ma JZ, Lu JL, et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant. 2015;2:282–7.
Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev. 1996;1:45–63.
De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999;1:151–64.
Xu G, Yan W, Li J. An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin Exp Nephrol. 2014;6:837–43.
Zhang Y, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol. 2014;5:1624–32.
Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;3:523–8.
Fan J, Yan P, Wang Y, Shen B, Ding F, Liu Y. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monit. 2016:1171–9.
Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M. et al. Thyroid function and cardiovascular events in chronic kidney disease patients. J Nephrol. 2016.
Ramirez G, O’Neill Jr W, Jubiz W, Bloomer HA. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Intern Med. 1976;6:672–6.
Mohamedali M, Reddy Maddika S, Vyas A, Iyer V, Cheriyath P. Thyroid disorders and chronic kidney disease. Int J Nephrol. 2014:520281.
Jusufovic S, Hodzic E. Functional thyroid disorders are more common in patients on chronic hemodialysis compared with the general population. Mater Sociomed. 2011;4:206–9.
Kutlay S, Atli T, Koseogullari O, Nergizoglu G, Duman N, Gullu S. Thyroid disorders in hemodialysis patients in an iodine-deficient community. Artif Organs. 2005;4:329–32.
Lin CC, Chen TW, Ng YY, Chou YH, Yang WC. Thyroid dysfunction and nodular goiter in hemodialysis and peritoneal dialysis patients. Perit Dial Int. 1998;5:516–21.
Shantha GP, Kumar AA, Bhise V, Khanna R, Sivagnanam K, Subramanian KK. Prevalence of subclinical hypothyroidism in patients with end-stage renal disease and the role of serum albumin: a cross-sectional study from south India. Cardiorenal Med. 2011;4:255–60.
Da Costa AB, Pellizzari C, Carvalho GA, Sant’Anna BC, Montenegro RL, Zammar Filho RG, et al. High prevalence of subclinical hypothyroidism and nodular thyroid disease in patients on hemodialysis. Hemodial Int. 2016;1:31–7.
Fragidis S, Sombolos K, Thodis E, Panagoutsos S, Mourvati E, Pikilidou M, et al. Low T3 syndrome and long-term mortality in chronic hemodialysis patients. World J Nephrol. 2015;3:415–22.
Fernandez-Reyes MJ, Diez JJ, Collado A, Iglesias P, Bajo MA, Estrada P, et al. Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients? Clin Nephrol. 2010;3:238–40.
Rhee CM, Kim S, Gillen DL, Oztan T, Wang J, Mehrotra R, et al. Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients. J Clin Endocrinol Metab. 2015;4:1386–95.
Rhee CM, Alexander EK, Bhan I, Brunelli SM. Hypothyroidism and mortality among dialysis patients. Clin J Am Soc Nephrol. 2013;4:593–601.
Kang EW, Nam JY, Yoo TH, Shin SK, Kang SW, Han DS, et al. Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients. Am J Nephrol. 2008;6:908–13.
Pamanes Gonzalez J, Gamboa Ortiz FA, Torres Ceniceros LF. Frequency of altered levels of thyroid hormones in patients undergoing peritoneal dialysis. Gac Med Mex. 2014:222–7.
Kerr DJ, Singh VK, Tsakiris D, McConnell KN, Junor BJ, Alexander WD. Serum and peritoneal dialysate thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis. Nephron. 1986;3:164–8.
Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis. 2001;4 Suppl 1:S80–4.
Diez JJ, Iglesias P, Selgas R. Pituitary dysfunctions in uremic patients undergoing peritoneal dialysis: a cross sectional descriptive study. Adv Perit Dial. 1995:218–24.
Semple CG, Beastall GH, Henderson IS, Thomson JA, Kennedy AC. Thyroid function and continuous ambulatory peritoneal dialysis. Nephron. 1982;3:249–52.
Robey C, Shreedhar K, Batuman V. Effects of chronic peritoneal dialysis on thyroid function tests. Am J Kidney Dis. 1989;2:99–103.
Rhee CM. Low-T3 syndrome in peritoneal dialysis: metabolic adaptation, marker of illness, or mortality mediator? Clin J Am Soc Nephrol. 2015;6:917–9.
Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2007;2:538–44.
Chang TI, Nam JY, Shin SK, Kang EW. Low triiodothyronine syndrome and long-term cardiovascular outcome in incident peritoneal dialysis patients. Clin J Am Soc Nephrol. 2015;6:975–82.
Jung HY, Cho JH, Jang HM, Kim YS, Kang SW, Yang CW, et al. Free thyroxine level as an independent predictor of infection-related mortality in patients on peritoneal dialysis: a prospective multicenter cohort study. PLoS One. 2014;12, e112760.
Perez SR, Diez JJ, Bajo MA, Iglesias P, Grande C, del Peso G, et al. Thyrotropin and free thyroxine concentrations do not affect cardiovascular disease and mortality in euthyroid peritoneal dialysis patients. Perit Dial Int. 2013;6:697–700.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;4:526–34.
Junik R, Wlodarczyk Z, Masztalerz M, Odrowaz-Sypniewska G, Jendryczka E, Manitius J. Function, structure, and volume of thyroid gland following allogenic kidney transplantation. Transplant Proc. 2003;6:2224–6.
Reinhardt W, Misch C, Jockenhovel F, Wu SY, Chopra I, Philipp T, et al. Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol. 1997;5:563–9.
Song SH, Kwak IS, Lee DW, Kang YH, Seong EY, Park JS. The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone. Nephrol Dial Transplant. 2009;5:1534–8.
Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, et al. Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant. 2002;1:57–61.
Lebkowska U, Malyszko J, Mysliwiec M. Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. Transplant Proc. 2003;8:2945–8.
Papalia T, Greco R, Lofaro D, Mollica A, Bonofiglio R. Thyroid status and kidney transplantation outcomes. Transplant Proc. 2011;4:1042–4.
Halilcevic A, Hodzic E, Mesic E, Trnacevic S. Incidence of subclinical hypothyroidism in renal transplant patients. Mater Sociomed. 2015;2:108–11.
Engels EA, Pfeiffer RM, Fraumeni Jr JF, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;17:1891–901.
Pond F, Serpell JW, Webster A. Thyroid cancer in the renal transplant population: epidemiological study. ANZ J Surg. 2005;3:106–9.
Yanik EL, Clarke CA, Snyder JJ, Pfeiffer RM, Engels EA. Variation in cancer incidence among patients with ESRD during kidney function and nonfunction intervals. J Am Soc Nephrol. 2016;5:1495–504.
Danzi S, Klein I. Amiodarone-induced thyroid dysfunction. J Intensive Care Med. 2015;4:179–85.
Luciani R, Falcone C, Principe F, Punzo G, Mene P. Acute renal failure due to amiodarone-induced hypothyroidism. Clin Nephrol. 2009;1:79–80.
El Ters M, Patel SM, Norby SM. Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize. Endocr Pract. 2014;5:490–9.
Hamed SA. The effect of antiepileptic drugs on thyroid hormonal function: causes and implications. Expert Rev Clin Pharmacol. 2015;6:741–50.
Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study. JAMA Psychiatry. 2015;12:1182–91.
Fagiolini A, Kupfer DJ, Scott J, Swartz HA, Cook D, Novick DM, et al. Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. Epidemiol Psichiatr Soc. 2006;2:123–7.
Tsui KY. The impact of Lithium on thyroid function in Chinese psychiatric population. Thyroid Res. 2015:14,015-0026-2. eCollection 2015.
Weiner ID, Leader JP, Bedford JJ, Verlander JW, Ellis G, Kalita P. et al. Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiol Rep. 2014;12. doi:10.14814/phy2.12242.
Alsady M, Baumgarten R, Deen PM, de Groot T. Lithium in the Kidney: friend and foe?. J Am Soc Nephrol. J Am Soc Nephrol. 2016;27:1587–95.
Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M, et al. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. J Clin Psychiatry. 2014;7:e672–8.
Paydas S, Balal M, Karayaylali I, Seyrek N. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy. Adv Ther. 2005;3:241–3.
Chen Y, Bao H, Liu Z, Zhang H, Zeng C, Liu Z, et al. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement. J Nephrol. 2014;2:159–64.
Zoccali C, Mallamaci F. Thyroid function and clinical outcomes in kidney failure. Clin J Am Soc Nephrol. 2012;1:12–4.
Rhee CM, Brent GA, Kovesdy CP, Soldin OP, Nguyen D, Budoff MJ, et al. Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrol Dial Transplant. 2015;5:724–37.
Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E, et al. Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol. 2011;4:305–12.
Meuwese CL, Dekkers OM, Stenvinkel P, Dekker FW, Carrero JJ. Nonthyroidal illness and the cardiorenal syndrome. Nat Rev Nephrol. 2013;10:599–609.
Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med. 2007;6:690–701.
Meuwese CL, Dekker FW, Lindholm B, Qureshi AR, Heimburger O, Barany P, et al. Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2012;1:131–8.
Koo HM, Kim CH, Doh FM, Lee MJ, Kim EJ, Han JH, et al. The impact of low triiodothyronine levels on mortality is mediated by malnutrition and cardiac dysfunction in incident hemodialysis patients. Eur J Endocrinol. 2013;4:409–19.
Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V, et al. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis. 2014;6:988–96.
Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, et al. Thyroid function and cardiovascular events in chronic kidney disease patients. J Nephrol. 2016.
Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;1:1–13.